Faculty of Medicine

Research on Chicken Pox Virus Paves Way for Promising HIV Vaccine

Feb 1, 2019

Graphical AbstractA study led by researchers at the University of Toronto and the University of Manitoba has brought science one step closer to using the chickenpox virus to develop a vaccine against HIV.

Scientists have long seen the chickenpox virus in vaccine form as a potential “vector” or carrier to deliver HIV genes and generate immunity to HIV, but safety concerns about this approach have limited further advances.

The new study is the first to show that chickenpox vaccine does not trigger an unwanted ‘HIV-welcoming’ immune state in the genital mucosa — as was seen in a previous clinical trial that used a similar viral vector — or in the bloodstream.

“Our study investigated an important safety concern that posed a barrier to this vaccine strategy,” said Kelly MacDonald, a professor of immunology at U of T and of internal medicine, immunology and medical microbiology at U of M. “The stage is now set to test a chickenpox-based HIV vaccine.”

The Journal of Clinical Investigation published the paper online January 22.

The researchers conducted their study in Kenya, a country severely affected by the HIV epidemic. Study participants were 44 healthy, HIV-negative women who were at low risk for HIV exposure and tested positive for immunity to chickenpox.

Lead author and U of T graduate student Dr. Catia Perciani worked with researchers from the Kenya AIDS Vaccine Initiative — Institute of Clinical Research at the University of Nairobi to give study participants a high-dose vaccine against only chickenpox virus. The researchers then tested each participant’s blood, as well as mucosal cells from the cervix and rectum at intervals of four, eight and 12 weeks.

The key finding was that 12 weeks post-vaccination, there was no significant difference in the frequency of activated HIV target cells, compared to pre-vaccination.

Professor Kelly MacDonaldProfessor Kelly MacDonald The study also showed that the vaccine vigorously boosted the women’s existing immunity to chickenpox, in their bloodstream but also in the genital area. This immune response in the genital area, where HIV infection first occurs, is a highly positive finding for the HIV vaccine concept, MacDonald said.  

A blended chickenpox and HIV vaccine would take advantage of the fact that chickenpox virus undergoes silent cycles of reactivation in the body. Each time it ‘wakes up’ from its dormant state, the body’s immunity quickly controls it and the immunity is boosted.

“The idea is to insert HIV genes into the Chickenpox virus like extra beads on a necklace. As the Varicella genes or ‘beads’ are made into protein, the HIV genes also get made into proteins and therefore stimulate immunity to HIV without the risk of giving the actual HIV virus,” MacDonald said. “We expect that each time the chickenpox virus is reactivated, it will also refresh immunity to HIV.”

MacDonald said the next steps are to continue testing the vaccine strategy using non-human primates and start developing a chickenpox virus-vectored HIV vaccine for a clinical trial in humans.

The study was supported by the Canadian Institutes of Health Research. Files for this story courtesy of the University of Manitoba.

Jun 21 Continuing Education Rounds: LDCT Lung Cancer Screening - Let’s Get Ready!
Grand Rounds | 8:00am–9:00am
Jun 22 Atherosclerosis in South Asians: Partnering for a Healthier Future
Symposium | 8:00am–3:00pm
Jun 25 Faculty of Medicine Staff Recognition BBQ
Other | 12:00pm–2:30pm
Jun 27 SEEDing Innovation: First Annual XSeed and EMHSeed Poster Session
Other | 1:00pm–3:00pm
Jul 3 WebPac Training
Workshop/Seminar | 2:00pm–3:30pm
Sep
11 – 14
International Society for the Advancement of Clinical MEG: Epilepsy and Beyond
Symposium | 7:00am–5:00pm
Sep
20 – 22
34th Annual Organ Imaging Review
Conference | 7:15am–5:15pm

Tweets

UofT Medicine
@uoftmedicine
RT : Does early consultation with a physical medicine and rehab doctor benefit people with traumatic injuries or burns?… https://t.co/HtXapRPb8h
UofT Medicine
@uoftmedicine
Providing inclusive care to the trans community: Prof Thea Weisdorf & Nurse Practitioner Sue Hranilovic sp… https://t.co/SygefNsJt7
UofT Medicine
@uoftmedicine
RT : From to immigrant integration: 56 researchers supported by Canada Research Chairs Program https://t.co/rqZhpfcJcB

UofTMed Magazine

Have we lost the art of dying?

Sign up for your free digital copy.